Epsilon M&A Deal Report - Rocamed SAM
Transaction Multiples for the Valuation of Private Companies
Private Group led by 21 Invest / Rocamed SAM
No EMAT :
122117
Announced Date :
02/08/2024
Type :
LBO (Leverage Buy Out)
Deal Value :
Yes
Acquirer :
Private Group led by 21 Invest
Target :
Rocamed SAM
Country :
Monaco
Sector of activity :
- Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Medical Equipment
- Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Medical Supplies
Business Description :
Founded in 2002, Rocamed is a medical device company specializing in sterile single-use solutions which designs, manufactures and distributes endoscopic disposables. > Products are dedicated to:...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
ns | |||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Medical Equipment » = 236
- Number of EMAT Reports / sub-sector « Medical Supplies » = 75
| Date | Acquirer | Target | Country | Multiples | See details |
| 07/02/2025 | Private Group led by LBO France | Hemodia | France | ** | 121872 |
| 12/10/2023 | Simago France | GRIM 37 (Grim+) | France | * | 121818 |
Source: Epsilon Research / EMAT
